Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Tanavij Pannoi, Chissanupong Promchai, Penjamaporn Apiromruck, Suwikran Wongpraphairot, Chen-Chang Yang & Wen-Chi Pan. (2022) Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand. International Journal of Nephrology and Renovascular Disease 15, pages 371-381.
Read now
Read now
Sachin Ananth,Alessio Navarra,Rama Vancheeswaran,. (2022) Obese, non-eosinophilic asthma: frequent exacerbators in a real-world setting. Journal of Asthma 59:11, pages 2267-2275.
Read now
Read now
Fränce Hardtstock, Ulf Maywald, Hartmut Timmermann, Victoria Unmüßig, Sabrina Müller, Thomas Wilke & Robert Welte. (2022) Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set. Journal of Asthma 59:4, pages 829-839.
Read now
Read now
Michael Asamoah-Boaheng, Kwadwo Osei Bonsu, Jamie Farrell, Alwell Oyet & William K Midodzi. (2021) Measuring Medication Adherence in a Population-Based Asthma Administrative Pharmacy Database: A Systematic Review and Meta-Analysis. Clinical Epidemiology 13, pages 981-1010.
Read now
Read now
Hamzah Bakouni, Lia Gentil & Helen-Maria Vasiliadis. (2019) Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults. Patient Preference and Adherence 13, pages 891-899.
Read now
Read now
Daisy Ng-Mak, Rachel Halpern, Krithika Rajagopalan & Antony Loebel. (2019) Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics. Current Medical Research and Opinion 35:2, pages 211-219.
Read now
Read now
Articles from other publishers (32)
Kanya K. Shah, Daniel R. Touchette & Joel C. Marrs. (2023) Research and scholarly methods: Measuring medication adherence. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 6:4, pages 416-426.
Crossref
Crossref
Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Jong-Shiuan Yeh, Wan-Ting Chen, Brian Tomlinson, Weng-Chio Tam & Li-Nien Chien. (2023) Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Motahareh Sadat Mirhaj Mohammadabadi, Homa Mohammadsadeghi, Mehrdad Eftekhar Adrebili, Zahra Partovi Kolour, Fatemeh Kashaninasab, Vahid Rashedi & Mohammadreza Shalbafan. (2022) Factors associated with pharmacological and psychotherapy treatments adherence in patients with borderline personality disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Ida Dragvoll, Anna M. Bofin, Håvard Søiland, Gunnar Taraldsen & Monica Jernberg Engstrøm. (2022) Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer. BMC Cancer 22:1.
Crossref
Crossref
Si Kei Vong, Lifeng Kang & Stephen R. Carter. (2022) Consumers’ self-reported adherence to directions for non-prescription medicines and the role of risk perception. Research in Social and Administrative Pharmacy 18:11, pages 3929-3938.
Crossref
Crossref
Joyce C. Chang & Karen H. Costenbader. (2022) Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 56, pages 152042.
Crossref
Crossref
Michael L. Parchman, Jennifer Perloff & Grant Ritter. (2022) Can clinician champions reduce potentially inappropriate medications in people living with dementia? Study protocol for a cluster randomized trial. Implementation Science 17:1.
Crossref
Crossref
Kevin E. ToddJr.Jr., Meghan E. McGrady, Edith Starbuck, Melissa Previtera & Lori Luchtman‐Jones. (2022) A systematic review of adherence to anticoagulation regimens in pediatric patients. Pediatric Blood & Cancer 69:7.
Crossref
Crossref
Danielle S. Chun, Blánaid Hicks, Sharon Peacock Hinton, Michele Jonsson Funk, Kyna Gooden, Alexander P. Keil, Hung-Jui Tan, Til Stürmer & Jennifer L. Lund. (2022) Comparison of Approaches for Measuring Adherence and Persistence to Oral Oncologic Therapies in Patients Diagnosed with Metastatic Renal Cell Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 31:4, pages 893-899.
Crossref
Crossref
Amanda Bevan, Zhe Hui Hoo, Nikki Totton, Carla Girling, India R. Davids, Pauline Whelan, Steven Antrobus, John Ainsworth, Iain Buchan, Alan Anderson, Stephen Bourke, Simon Doe, Carlos Echevarria, Jill Taylor, Nicholas J. Bell, Kathryn Bateman, Carys Jones, Peter Moran, Giles Fitch, Michael Martin, Angela McGowan, Stephen Morrow, Heather Seabridge, Nicki Bush, Tracey Daniels, Katy Lee, Nicola Robson, Dejene Shiferaw, Dimah Sweis, Rebecca Thomas, Jayne Faulkner, William G. Flight, Sarah Poole, Louise Warnock, Mark I. Allenby, Mary Carroll, Thomas V. Daniels, Helen Dunn, Julia A. Nightingale, Elizabeth Shepherd, Chandra Ohri, Jessica Gadsby, Simon Range, Darren Tature, Helen L. Barr, Sophie Dawson, Jane Dewar, Bryony Miller, Gauri Saini, Penny Galey, Jack Johnson, Mark C. Pasteur, David Derry, Harriet Gledhill, Angharad Lawson, Michelle Thomas, David Waine, Josie Cunningham, Annant Damani, Alexandra Higton, Christopher Orchard, Charlotte Carolan, Misbah Tahir, Amanda Plummer, Marlene Hutchings, Frank P Edenborough, Rachael Curley & Martin J. Wildman. (2022) Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis. Journal of Cystic Fibrosis 21:2, pages 323-331.
Crossref
Crossref
Valentina Maria Caso, Simona Sperlongano, Biagio Liccardo, Emanuele Romeo, Sergio Padula, Fortunato Arenga, Antonello D’Andrea, Pio Caso, Paolo Golino, Gerardo Nigro & Vincenzo Russo. (2022) The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy. Journal of Clinical Medicine 11:3, pages 475.
Crossref
Crossref
Pascal C. Baumgartner, Bernard Vrijens, Samuel Allemann, Kurt E. Hersberger & Isabelle Arnet. (2022) Delta T, a Useful Indicator for Pharmacy Dispensing Data to Monitor Medication Adherence. Pharmaceutics 14:1, pages 103.
Crossref
Crossref
Sajjad Haider, Sheikh Abdul Khaliq, Syed Baqir Naqvi & Anab Fatima. (2022) Medication possession ratio in postmenopausal osteoporotic patients: a cross sectional study. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Crossref
Frodi Fridason Jensen, Kjell E. J. Håkansson, Britt Overgaard Nielsen, Ulla Møller Weinreich & Charlotte Suppli Ulrik. (2021) Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma. Asthma Research and Practice 7:1.
Crossref
Crossref
Rafia S. Rasu, Suzanne L. Hunt, Junqiang Dai, Huizhong Cui, Milind A. Phadnis & Nishank Jain. (2020) Accurate Medication Adherence Measurement Using Administrative Data for Frequently Hospitalized Patients. Hospital Pharmacy 56:5, pages 451-461.
Crossref
Crossref
Meng-Ting Wang, Jyun-Heng Lai, Ya-Ling Huang, Jun-Ting Liou, Shih-Hsuan Cheng, Chen Wei Lin, Hsueh-Yi Pan, Yu-Juei Hsu & Chen-Liang Tsai. (2021) Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study. Chest 160:4, pages 1255-1270.
Crossref
Crossref
Chi-Shin Wu, Le-Yin Hsu, Yi-Jiun Pan & Shi-Heng Wang. (2021) Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Jiae Shin, Dongwoo Ham, Hee Young Paik, Sangah Shin & Hyojee Joung. (2021) Gender Differences in the Risk of Ischemic Heart Disease According to Healthcare Utilization and Medication Adherence among Newly Treated Korean Hypertensive Patients. International Journal of Environmental Research and Public Health 18:3, pages 1274.
Crossref
Crossref
Ming Tsuey Lim, Norazida Ab Rahman, Xin Rou Teh, Chee Lee Chan, Shantini Thevendran, Najwa Ahmad Hamdi, Ka Keat Lim & Sheamini Sivasampu. (2021) Optimal cut-off points for adherence measure among patients with type 2 diabetes in primary care clinics: a retrospective analysis. Therapeutic Advances in Chronic Disease 12, pages 204062232199026.
Crossref
Crossref
Joyce C. Chang, Alaina M. Davis, Marisa S. Klein‐Gitelman, Zuleyha Cidav, David S. Mandell & Andrea M. Knight. (2020) Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth With Systemic Lupus Erythematosus. Arthritis Care & Research 73:1, pages 30-38.
Crossref
Crossref
Ian Duncan, Terri L. Maxwell, Nhan Huynh & Marisa Todd. (2020) Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients. American Journal of Hospice and Palliative Medicine® 37:12, pages 1076-1085.
Crossref
Crossref
Patrick Vermersch, Laurent Suchet, Renato Colamarino, Caroline Laurendeau & Bruno Detournay. (2020) An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017. Multiple Sclerosis and Related Disorders 46, pages 102521.
Crossref
Crossref
Andreas Fontalis & Richard Eastell. (2020) The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis. Bone 136, pages 115336.
Crossref
Crossref
Evan L. Reynolds, James F. Burke, Mousumi Banerjee, Kevin A. Kerber, Lesli E. Skolarus, Brandon Magliocco, Gregory J. Esper & Brian C. Callaghan. (2020) Association of out-of-pocket costs on adherence to common neurologic medications. Neurology 94:13, pages e1415-e1426.
Crossref
Crossref
Yu.V. Lukina, N.P. Kutishenko, S.Yu. Martsevich, R.N. Shepel & O.M. Drapkina. (2020) Methodological recommendations: "Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations". Profilakticheskaya meditsina 23:3, pages 42.
Crossref
Crossref
Chin-Shien Lin, Haider Khan, Ruei-Yuan Chang, Wei-Chih Liao, Yi-Hsin Chen, Sih-Yin Siao & Teng-Fu Hsieh. (2020) A study on the impact of poor medication adherence on health status and medical expense for diabetes mellitus patients in Taiwan. Medicine 99:26, pages e20800.
Crossref
Crossref
John A. Romley, Zhiwen Xie, Tommy Chiou, Dana Goldman & Anne L. Peters. (2019) Extended-Release Formulation and Medication Adherence. Journal of General Internal Medicine 35:1, pages 354-356.
Crossref
Crossref
Oliver FreudenreichOliver Freudenreich. 2020. Psychotic Disorders. Psychotic Disorders
411
423
.
Kiki CheungKatia M.C. VerhammeRon HeringsLoes E. VisserBruno H. Stricker. (2019) Methylphenidate Treatment Initiated During Childhood Is Continued in Adulthood in Half of the Study Population. Journal of Child and Adolescent Psychopharmacology 29:6, pages 426-432.
Crossref
Crossref
Pascal C. Baumgartner, R. Brian Haynes, Kurt E. Hersberger & Isabelle Arnet. (2018) A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes. Frontiers in Pharmacology 9.
Crossref
Crossref
Margret V. Bjarnadottir, David Czerwinski & Eberechukwu Onukwugha. (2017) Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases. PharmacoEconomics 36:3, pages 369-380.
Crossref
Crossref